Pathogenomics of MycobacteriaGutierrez M.C.a · Supply P.b · Brosch R.c
aInstitut Pasteur, Department Infection and Epidemiology, Paris, bINSERM U629 and Institut Pasteur de Lille, Lille, cInstitut Pasteur, UP Pathogénomique Mycobactérienne Intégrée, Paris, France
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Among the 130 species that constitute the genus Mycobacterium, the great majority are harmless saprophytes. However, a few species have very efficiently adapted to a pathogenic lifestyle. Among them are two of the most important human pathogens, Mycobacterium tuberculosis and Mycobacterium leprae, and one emerging pathogen, Mycobacterium ulcerans. Their slow growth, virulence for humans and particular physiology make these organisms very difficult to work with, however the need to develop new strategies in the fight against these pathogens requires a clear understanding of their genetic and physiological repertoires and the mechanisms that have contributed to their evolutionary success. The rapid development of mycobacterial genomics following the completion of the Mycobacterium tuberculosis genome sequence provides now the basis for finding the important factors distinguishing pathogens and non-pathogens. In this chapter we will therefore present some of the major insights that have been gained from recent studies, with focus on the roles played by various evolutionary processes in shaping the structure of mycobacterial genomes and pathogen populations.
© 2009 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.